HomeRMTI • NASDAQ
Follow
Rockwell Medical Inc
Previous close
$1.60
Day range
$1.51 - $1.59
Year range
$1.16 - $6.24
Market cap
44.74M USD
Avg Volume
278.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 22.09M | 14.39% |
Operating expense | 3.42M | -20.65% |
Net income | -1.51M | 35.99% |
Net profit margin | -6.84 | 44.07% |
Earnings per share | — | — |
EBITDA | 3.00K | 100.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.94M | -49.12% |
Total assets | 52.17M | 11.88% |
Total liabilities | 30.88M | -5.06% |
Total equity | 21.29M | — |
Shares outstanding | 29.33M | — |
Price to book | 2.19 | — |
Return on assets | -2.61% | — |
Return on capital | -3.85% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -1.51M | 35.99% |
Cash from operations | -43.00K | 61.61% |
Cash from investing | 2.01M | -37.60% |
Cash from financing | -742.00K | 87.60% |
Net change in cash | 1.22M | 142.53% |
Free cash flow | 373.62K | -83.01% |
About
Rockwell Medical Inc. is a company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
237
